Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review
Giuseppe Bartolomei
Frontiers in Psychiatry, 2018
View PDFchevron_right
Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use
Frans Zitman
Acta Psychiatrica Scandinavica, 2009
View PDFchevron_right
Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort
Rosemary Khoury
Psychological Medicine
View PDFchevron_right
Metabolic Syndrome and Cardiovascular Disease Risk in patients with Depressive disorder on Antidepressive Medication
Vijay Choudhary
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018
View PDFchevron_right
Association of first-line antidepressants and incident adverse metabolic effects
Frances Wen
Canadian Family Physician, 2020
View PDFchevron_right
Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
Victor Lameda
Vessel Plus
View PDFchevron_right
Metabolic syndrome in drug-naïve patients with Depressive Disorders
subho chakrabarti
Indian Journal of Psychological Medicine, 2013
View PDFchevron_right
Review Open Access Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable
Vessel Plus, Mervin Chávez
vessel plus, 2018
View PDFchevron_right
Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: Results from the PPP-Botnia Study
Sarah Knox
Annals of Medicine, 2011
View PDFchevron_right
Prevalence of metabolic syndrome among patients with major depressive disorder--differences between newly diagnosed first episode and recurrent disease
Hrvoje Jakovac
Collegium antropologicum, 2013
View PDFchevron_right
Bidirectional Prospective Associations of Metabolic Syndrome Components with Depression, Anxiety, and Antidepressant Use
Dóra Révész
Depression and anxiety, 2016
View PDFchevron_right
Metabolic Syndrome in Patients with Depression: A Cross-sectional Comparative Study
shalu abraham
Indian journal of private psychiatry, 2023
View PDFchevron_right
Major depression and metabolic syndrome
Michael Deuschle
Psychoneuroendocrinology, 2000
View PDFchevron_right
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease A Real-Life Investigation From Italy
Niccolò Lombardi
View PDFchevron_right
Relations of Depressive Symptoms and Antidepressant Use to Body Mass Index and Selected Biomarkers for Diabetes and Cardiovascular Disease
Barbara Olendzki
American Journal of Public Health, 2013
View PDFchevron_right
An examination of the moderating effect of treatment with anti-depressants on the association of heart disease with depression in males with type 2 diabetes attending a Veterans Affairs Medical Center
Barbara Stetson
Diabetes Research and Clinical Practice, 2007
View PDFchevron_right
The lack of association between components of metabolic syndrome and treatment resistance in depression
Ivan Barisic
Psychopharmacology, 2013
View PDFchevron_right
Metabolic Syndrome and Onset of Depressive Symptoms in the Elderly: Findings from the Three-City Study
I. Jaussent
Diabetes Care, 2011
View PDFchevron_right
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
Jakub Konarski
Expert Opinion on Drug Safety, 2006
View PDFchevron_right
The Association between Antidepressant Use and Disturbances in Glucose Homeostasis: Evidence from Spontaneous Reports
Ronald Meyboom
Drug Safety, 2007
View PDFchevron_right
Association between metabolic syndrome, hypertension, and chronic depression: a postmenopausal women prevention study
Pasquale Palmiero
Italian Journal of Medicine, 2023
View PDFchevron_right
Metabolic Effects of Antidepressants: Results of a Randomized Study’s Interim Analysis
Dr. Jyoti Prakash Sahoo
Cureus
View PDFchevron_right
Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study
Linda Lévesque
Archives of Internal Medicine, 2009
View PDFchevron_right
Prevalence of the metabolic syndrome in unipolar major depression
Ulrich Schweiger
European Archives of Psychiatry and Clinical Neuroscience, 2012
View PDFchevron_right
Major Depression, Antidepressant Medication and the Risk of Obesity
Scott Patten
Psychotherapy and Psychosomatics, 2009
View PDFchevron_right
Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies
Annalisa Biffi
European Journal of Clinical Pharmacology, 2017
View PDFchevron_right
Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression
Majid Sadeghi
DARU Journal of Pharmaceutical Sciences, 2013
View PDFchevron_right
Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
David Marrero
Diabetes Care, 2010
View PDFchevron_right